Esophageal stent placement and dysphagia scores and complications of therapy in Esophageal Cancer - Clinical Trials Registry

Study Overview

Status

Completed

Conditions

Esophageal Cancer

Intervention / Treatment

Detailed Description

Esophageal cancer is common in some areas , ranking as the fourth leading cause of death from cancer in China and sixth worldwide. Although the prognosis of surgical resection for esophageal cancer has been improved, more than 50% of such patients are inoperable and have to undergo palliative treatments because of late stage cancer or metastasis. Dysphagia is the predominate symptom of patients with inoperable esophageal cancer. To relieve the dysphagia and improve the quality of life of such patients, brachytherapy has previously been utilized. Recently, stent placement has been widely accepted to be an option for palliation of the symptoms due to the esophageal strictures. However, recurrence of the neoplastic stricture remains a challenge after stent placement. To combine the advantages of the immediate relief of the esophageal dysphagia with the stent placement and radiation therapy with brachytherapy, a novel esophageal stent loaded with 125I seeds has been developed in the authors' institute. The technical feasibility and safety with this new stent has been demonstrated to be adequate in a healthy rabbit model. The current study is designed to demonstrate the preliminary results with this irradiation stent in patients with inoperable esophageal cancer compared to those using a conventional covered stent.

Study Type

Interventional

Enrollment (Actual)

60

Phase

Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

China
- Jiangsu
  - Nanjing, Jiangsu, China, 210009
    - Zhongda Hospital, Southeast University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Histologically confirmed primary cancer of esophagus,
Must be dysphagia caused by esophageal cancer,
Surgically inoperable, but may be metastatic,
Without esophageal fistulas,
Must be an inpatient at Zhongda Hospital,
Life expectancy is over 6 months,

Exclusion Criteria:

Esophageal fistulas,
Tracheal compression with symptoms,
WBC <2000/mm3 and Platelet count <50,000/mm3,
Concurrent therapies:surgery, chemotherapy,radiotherapy, Traditional Chinese Medicine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Single Group Assignment
Masking: Single

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Relief of dysphagia measured by dysphagia scores, survival time from the interventional procedure to the last follow-up. Time Frame: Follow-up in intervals of 1, 3, 6 and 12 months after stent placement	Follow-up in intervals of 1, 3, 6 and 12 months after stent placement

Secondary Outcome Measures

Outcome Measure	Time Frame
Successful rate of stent placement, Stent-related complications and morbidity, Overall rate of mortality Time Frame: Follow-up in intervals of 1, 3, 6, and 12 months after stent placement	Follow-up in intervals of 1, 3, 6, and 12 months after stent placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Southeast University, China

Investigators

Principal Investigator: Gao-Jun Teng, MD. Ph.D, Zhongda hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Guo JH, Teng GJ, Zhu GY, He SC, Deng G, He J. Self-expandable stent loaded with 125I seeds: feasibility and safety in a rabbit model. Eur J Radiol. 2007 Feb;61(2):356-61. doi: 10.1016/j.ejrad.2006.10.003. Epub 2006 Nov 7.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2004

Study Completion (Actual)

December 1, 2006

Study Registration Dates

First Submitted

May 22, 2007

First Submitted That Met QC Criteria